0000899243-18-006553.txt : 20180306 0000899243-18-006553.hdr.sgml : 20180306 20180306202916 ACCESSION NUMBER: 0000899243-18-006553 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180302 FILED AS OF DATE: 20180306 DATE AS OF CHANGE: 20180306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mauro Anthony CENTRAL INDEX KEY: 0001534275 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 18671672 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-02 0 0001623613 Mylan N.V. MYL 0001534275 Mauro Anthony BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL UNITED KINGDOM 0 1 0 0 Chief Commercial Officer Ordinary Shares 2018-03-02 4 M 0 4757 22.66 A 147435 D Ordinary Shares 2018-03-02 4 S 0 12257 40.35 D 135178 D Ordinary Shares 2018-03-03 4 M 0 5534 0.00 A 140712 D Ordinary Shares 2018-03-03 4 F 0 2310 40.97 D 138402 D Ordinary Shares 2018-03-04 4 M 0 2056 0.00 A 140458 D Ordinary Shares 2018-03-04 4 F 0 895 40.97 D 139563 D Ordinary Shares 2018-03-04 4 M 0 13880 0.00 A 153443 D Ordinary Shares 2018-03-04 4 F 0 5759 40.97 D 147684 D Ordinary Shares 5574 I By 401(k) Plan Employee Stock Option - Right to Buy 22.66 2018-03-02 4 M 0 4757 0.00 D 2021-03-02 Ordinary Shares 4757 0 D Employee Stock Option - Right to Buy 40.97 2018-03-02 4 A 0 29833 0.00 A 2028-03-02 Ordinary Shares 29833 29833 D Restricted Stock Units 0.00 2018-03-02 4 A 0 18307 0.00 A Ordinary Shares 18307 18307 D Restricted Stock Units 0.00 2018-03-03 4 M 0 5534 0.00 D Ordinary Shares 5534 11067 D Restricted Stock Units 0.00 2018-03-04 4 M 0 2056 0.00 D Ordinary Shares 2056 0 D Performance Restricted Stock Units 0.00 2018-03-04 4 M 0 13880 0.00 D Ordinary Shares 13880 0 D Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 2, 2011. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on November 17, 2015. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on November 17, 2015. The grant, of which these options were a part, vested in three equal installments beginning on March 2, 2012. 9,945 of the options will vest on March 2, 2019, and 9,944 of the options will vest on each of March 2, 2020 and March 2, 2021. The options expire on March 2, 2028. Each RSU represents the right to receive one ordinary share of Mylan N.V. 6,103 of the RSUs will vest on March 2, 2019, and 6,102 will vest on each of March 2, 2020 and March 2, 2021. Each RSU represents the right to receive one ordinary share of Mylan N.V. 5,534 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 5,534 will vest on March 3, 2019, and 5,533 will vest March 3, 2020. Each RSU represents the right to receive one ordinary share of Mylan N.V. 2,057 of the RSUs granted on November 17, 2015 vested on March 4, 2016, and 2,056 vested on each of March 4, 2017 and March 4, 2018. Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on November 17, 2015, subject to the attainment of previously established two-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018. /s/ Kevin Macikowski, by power of attorney 2018-03-06